Kewajiban jangka dawa marang ekuitas: Stereotaxis Corporation (STXS)

The Stereotaxis, Inc. (STXS) price trend on the GURU.Markets platform reflects long-term debt dynamics, which stand at 0.26. Stereotaxis, Inc. (STXS) is advancing robotic cardiac surgery by deploying the Genesis system to capture new markets. The business relies on medical automation, remaining resilient to economic cycles. Intellectual property protection and high switching costs for alternative software ensure stable service revenue.

This indicator is calculated as the ratio of liabilities with a maturity of more than one year to total equity, reflecting the company's dependence on external long-term financing. An analysis of financial leverage based on long-term debt allows for an assessment of the stability of Stereotaxis, Inc. (STXS) when scaling the production of robotic systems and service contracts, where low values confirm a secure capital structure and high business autonomy.